Announcements
Hemmerling A, Harrison W, Schroeder A, Park J, Korn A, Foster-Rosales A, Shiboski S, Cohen CR. Phase 2 clinical trial testing colonization efficiency, safety and acceptability of Lactobacillus crispatus CTV-05 (LACTIN-V) in women for the prevention of recurrent bacterial vaginosis. Presented at Microbicides 2010, May 22-25, 2010.
Ngugi B, Hemmerling A, Bukusi E, Kikuvi G, Gikunju J, Shiboski S, Fredericks D, Cohen C. Effects of BV-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05. Presented at Microbicides 2010, May 22-25, 2010.
Stapleton AE, Au-Yeung M, Yarova-Yarovaya Y, Fredricks DN, Czaja C, Scholes D, Hooton TM, Stamm WE. Double-blind, placebo controlled phase 2 trial of LACTIN-V vaginal Lactobacillus crispatus probiotic to prevent recurrent UTI. Presented at the 47th Annual Meeting of the IDSA, October 2009.
- Scientists Use Live Bacteria to Fight HIV - 7/20/2011
- Aidsmap News - 3/4/2008
- Genetic Engineering & Biotechnology News - 2/15/2007
- Associated Press News Report - 9/8/2003
- BBC News Report - 9/8/2003
- Osel PNAS - 09/30/2003